Report has been added to MarketsandMarkets offering Women’s Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care) – Global Forecast to 2025
Get Sample Copy of This Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=128928901
The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period. The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers are also expected to support the growth of this market during the forecast period.
The prenatal genetic screening & carrier testing segment is expected to grow at the highest CAGR during the forecast period
The prenatal genetic screening & carrier testing segment is projected to witness the highest growth in the women’s health diagnostics market during the forecast periods (2020-2025). Growth in this segment is driven mostly by the adverse effects of Down’s syndrome, Edwards’ syndrome, CF, and TORCH infections in infants, and increasing awareness among women regarding prenatal screening for these disorders.
The hospitals & clinics segment is expected to account for the largest share of the women’s health diagnostics market
The large share of this segment can be attributed to a greater proportion of patients (women) visiting hospitals to diagnose/treat health issues. Other factors such as growing consolidation among hospitals and the implementation of ACOs in the US are also expected to support the growth of this end-user segment in the coming years.
Enquire Before Buying this Report @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=128928901
Asia Pacific is expected to account for the highest CAGR for players operating in the women’s health diagnostics market
The Asia Pacific women’s health diagnostics market is expected to grow at the highest CAGR from 2020 to 2025. Improving healthcare infrastructures, growing per capita incomes, and the rising focus of key market companies in this region are major factors driving the growth of the APAC women’s health diagnostics market.
Premium Insights
· The breast cancer testing segment accounts for the largest share of the market
· Rising acceptance of POC diagnostics and PST practices is expected to drive the growth of this regional segment during the forecast period.
Market Dynamics
Drivers
· High prevalence of infectious diseases in women
Opportunity
· Growing number of regulatory approvals for immunoassay diagnostic techniques
Challenges
· Increasing adoption of refurbished diagnostic imaging systems
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Women’s Health Diagnostics, by Application
7 Women’s Health Diagnostics, by End-user
8 Women’s Health Diagnostics, by region
9 Competitive Landscape
10 Company Profiles
11 Appendix
Buy Now Full Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=128928901
